MGO One Seven LLC Purchases 41,302 Shares of Haleon plc (NYSE:HLN)

MGO One Seven LLC grew its holdings in Haleon plc (NYSE:HLN - Free Report) by 101.6% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 81,958 shares of the company's stock after acquiring an additional 41,302 shares during the quarter. MGO One Seven LLC's holdings in Haleon were worth $782,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the business. Wellington Management Group LLP boosted its holdings in shares of Haleon by 67.5% in the fourth quarter. Wellington Management Group LLP now owns 15,328,325 shares of the company's stock valued at $146,232,000 after buying an additional 6,175,835 shares during the period. Raymond James Financial Inc. bought a new position in Haleon during the 4th quarter worth about $42,193,000. FMR LLC lifted its holdings in shares of Haleon by 3.7% in the fourth quarter. FMR LLC now owns 108,827,814 shares of the company's stock valued at $1,038,217,000 after purchasing an additional 3,909,545 shares in the last quarter. Bank Julius Baer & Co. Ltd Zurich bought a new position in shares of Haleon during the fourth quarter worth about $39,628,000. Finally, JPMorgan Chase & Co. boosted its position in Haleon by 25.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 5,084,202 shares of the company's stock worth $53,791,000 after acquiring an additional 1,026,939 shares during the last quarter. Institutional investors own 6.67% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on HLN shares. HSBC restated a "hold" rating on shares of Haleon in a report on Wednesday, March 5th. Morgan Stanley cut Haleon from an "overweight" rating to an "equal weight" rating in a report on Friday, January 10th. Sanford C. Bernstein lowered shares of Haleon from an "outperform" rating to a "market perform" rating in a research report on Wednesday, January 8th. Hsbc Global Res downgraded shares of Haleon from a "strong-buy" rating to a "hold" rating in a report on Wednesday, March 5th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating on shares of Haleon in a report on Monday, March 3rd. Six analysts have rated the stock with a hold rating, one has given a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $10.95.

Haleon Stock Performance

Shares of NYSE HLN traded down $0.14 during trading on Wednesday, reaching $10.14. 17,713,012 shares of the stock traded hands, compared to its average volume of 7,470,543. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.84 and a quick ratio of 0.58. The stock has a market capitalization of $45.75 billion, a P/E ratio of 29.82, a price-to-earnings-growth ratio of 2.82 and a beta of 0.24. Haleon plc has a 52-week low of $8.12 and a 52-week high of $10.80. The company has a 50-day moving average of $10.15 and a 200-day moving average of $9.81.

Haleon (NYSE:HLN - Get Free Report) last posted its earnings results on Thursday, February 27th. The company reported $0.05 earnings per share for the quarter. The business had revenue of $3.54 billion for the quarter, compared to analyst estimates of $3.38 billion. Haleon had a net margin of 10.85% and a return on equity of 14.76%. Analysts forecast that Haleon plc will post 0.43 EPS for the current fiscal year.

Haleon Increases Dividend

The firm also recently announced a -- dividend, which will be paid on Thursday, June 5th. Investors of record on Friday, April 25th will be issued a dividend of $0.1166 per share. The ex-dividend date of this dividend is Friday, April 25th. This represents a dividend yield of 1.6%. This is a positive change from Haleon's previous -- dividend of $0.05. Haleon's dividend payout ratio (DPR) is currently 58.97%.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.